Shaistha Sing

Director Strategic International Regulatory Affairs at Acino

Shaistha Sing has a diverse work experience in the pharmaceutical industry. Shaistha is currently the Head of Regulatory Affairs for the Africa region and Responsible Pharmacist for South Africa at ACINO. Prior to this, they worked at Mylan as a Responsible Pharmacist and RA Manager, where they oversaw new product registrations, maintained existing products, reviewed promotional materials, and built relationships with health authorities. Before Mylan, they worked at Aspen Pharmacare as a Regulatory Affairs Specialist, handling new submissions in African territories and Latin America, as well as assessments by WHO and FDA authorities. Shaistha also had roles at Sandoz as a Production Lead Pharmacist, overseeing manufacturing activities, and at Aspen Pharma Group as a Production Pharmacist. Earlier in their career, they worked at the Department of Health KZN as a Principal ARV Pharmacist.

Shaistha Sing's education history includes:

- In 2019, they attended GIBS Business School (Gordon Institute of Business Science) for a degree in Managing for Results in the field of Management.

- From 2014 to 2018, they studied at the University of the Witwatersrand and obtained a Master of Science in Medicine (Pharmaceutical Affairs) with a focus on Regulatory Affairs.

- Between 2002 and 2005, they pursued a Bachelor of Pharmacy (BPharm) at Rhodes University, specializing in Pharmacology.

- Prior to these higher education experiences, they attended Richmond Primary School, although no specific years or degrees were provided for this period.

- Additionally, in 2021, they obtained a certification in Coaching Skills for Leaders and Managers from LinkedIn.

Location

Johannesburg, South Africa

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Acino

2 followers

Acino is a Swiss pharmaceutical company headquartered in Zurich, with a clear focus on high-growth markets. We deliver quality pharmaceuticals to promote affordable healthcare and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing. For more information: www.acino.swiss *** By engaging with Acino on LinkedIn (or any other Acino social media channel), you are agreeing to our Social Media Community Guidelines. If you do not agree to them, do not engage with Acino on social media. Please read our detailed community guidelines carefully here: https://acino.swiss/acino_social_media_community_guidelines_may2022 ***